Key facts
- This page summarizes W. Bryan Hill's Form 4 filing for ALKAMI TECHNOLOGY, INC. (ALKT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Jan 2025, 18:44.
W. Bryan Hill - 13 Jan 2025 Form 4 Insider Report for ALKAMI TECHNOLOGY, INC. (ALKT)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ALKT
- Reported as of
- 13 Jan 2025
- Net transaction value
- -$3,109,230
- SEC form
- 4
- Accepted by SEC
- 14 Jan 2025, 18:44:52 UTC
- Prior SEC filing
- 18 Dec 2024
- Next SEC filing
- 26 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Douglas A. Linebarger, as Attorney-in-Fact for W. Bryan Hill
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
W. Bryan Hill filed Form 4 for ALKAMI TECHNOLOGY, INC. (ALKT) on 14 Jan 2025.
Change
- Previous filing in this sequence was filed on 18 Dec 2024.
- Current net transaction value: -$3,109,230.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALKT
transaction
Common Stock
Options Exercise
- Transaction value
- $234,000
- Shares
- +100,000
- Change %
- +28%
- Price
- $2.34
- Shares after
- 453,841
- Date
- 13 Jan 2025
- Ownership
- Direct
ALKT
transaction
Common Stock
Sale
- Transaction value
- $3,343,230
- Shares
- -100,000
- Change %
- -22%
- Price
- $33.43
- Shares after
- 353,841
- Date
- 13 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALKT
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -100,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 13 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $2.34
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transaction of prices ranging from $33.06 to $33.86. The Reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The shares subject to the option are fully vested and exercisable.